Key Metrics
CiteScore 

1.1
H-Index 

24
Impact Factor 

< 5
SJR 

Q4Plant Science

SNIP 

0.62
Recommended pre-submission checks
Powered by 

Anales del Jardin Botanico de Madrid Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | CONSEJO SUPERIOR INVESTIGACIONES CIENTIFICAS-CSIC |
| Language | Spanish,English |
| Frequency | Semi-annual |
| Publication Time | 48 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | Spanish,English |
| Frequency | Semi-annual |
| Publication Start Year | 1940 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 48 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo,Dulcinea |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Anales del Jardin Botanico de Madrid ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Anales del Jardin Botanico de Madrid
Disrupting E3 ubiquitin ligase protein-protein interactions in cancer: chemical modalities, mechanisms, and therapeutic opportunities.
- 1 Aug 2026
- Biochemical pharmacology
Cipepofol attenuates endothelial barrier dysfunction in acute lung injury through DUSP1-dependent suppression of MAPK signaling.
- 1 Aug 2026
- Biochemical pharmacology
Tucatinib alleviates postmenopausal osteoporosis by suppressing osteoclast differentiation via regulating the DRP1/NFATc1/CTSK signaling pathway.
- 1 Aug 2026
- Biochemical pharmacology
Retraction notice to "Omentin-1 attenuates salt-sensitive hypertension via GRK4/AT1R downregulation mediated by the ROS/c-Myc pathway" [Biochem. Pharmacol. 243 (2026) 117489
- 1 Aug 2026
- Biochemical pharmacology
β-Hydroxybutyrate modulates intestinal barrier function and visceral sensitivity via a brain AMPK-orexin pathway recruiting histamine H1 receptors, basal forebrain cholinergic neurons, adenosine A2B receptors, and vagal output in rats.
- 1 Aug 2026
- Biochemical pharmacology
NPTX2 accelerates cell cycle progression, activates EMT, and regulates glycolytic metabolic pathways to promote clear cell renal cell carcinoma progression.
- 1 Aug 2026
- Biochemical pharmacology
Disrupting E3 ubiquitin ligase protein-protein interactions in cancer: chemical modalities, mechanisms, and therapeutic opportunities.
- 1 Aug 2026
- Biochemical pharmacology
Cipepofol attenuates endothelial barrier dysfunction in acute lung injury through DUSP1-dependent suppression of MAPK signaling.
- 1 Aug 2026
- Biochemical pharmacology
Tucatinib alleviates postmenopausal osteoporosis by suppressing osteoclast differentiation via regulating the DRP1/NFATc1/CTSK signaling pathway.
- 1 Aug 2026
- Biochemical pharmacology
Retraction notice to "Omentin-1 attenuates salt-sensitive hypertension via GRK4/AT1R downregulation mediated by the ROS/c-Myc pathway" [Biochem. Pharmacol. 243 (2026) 117489
- 1 Aug 2026
- Biochemical pharmacology
β-Hydroxybutyrate modulates intestinal barrier function and visceral sensitivity via a brain AMPK-orexin pathway recruiting histamine H1 receptors, basal forebrain cholinergic neurons, adenosine A2B receptors, and vagal output in rats.
- 1 Aug 2026
- Biochemical pharmacology
NPTX2 accelerates cell cycle progression, activates EMT, and regulates glycolytic metabolic pathways to promote clear cell renal cell carcinoma progression.
- 1 Aug 2026
- Biochemical pharmacology